The use of cylexin (CY-1503) in prevention of reperfusion lung injury in patients undergoing pulmonary thromboendarterectomy. [electronic resource]
Producer: 20000913Description: 14-20 p. digitalISSN:- 1073-449X
- Adult
- Aged
- Bronchoalveolar Lavage Fluid
- Double-Blind Method
- Endarterectomy -- adverse effects
- Female
- Humans
- Hypertension, Pulmonary -- etiology
- Lewis Blood Group Antigens -- therapeutic use
- Male
- Middle Aged
- Oligosaccharides -- therapeutic use
- Pulmonary Embolism -- complications
- Reperfusion Injury -- etiology
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.